论文部分内容阅读
目的探讨病毒性心肌炎采用丙种球蛋白治疗的临床效果。方法选取某院2008年1月~2010年8月诊治的46例病毒性心肌炎患者,将其均分成观察组和对照组两组,每组23例,对照组采用传统的治疗方法,观察组在传统治疗基础上采取丙种球蛋白进行治疗,然后对比两组治疗效果。结果观察组的总有效率为95.65%优于对照组的总有效率86.96%,两组效果对比差异有统计学意义(P<0.05),且所有患者均无副作用。结论对于病毒性心肌炎的治疗采用丙种球蛋白,治疗效果显著,提高疾病的治愈率,且无不良反应的发生,值得临床治疗广泛推广。
Objective To investigate the clinical effect of treatment of viral myocarditis with gamma globulin. Methods A total of 46 patients with viral myocarditis diagnosed and treated in our hospital from January 2008 to August 2010 were divided into observation group and control group, with 23 cases in each group. The control group was treated by traditional method and the observation group was divided into observation group Traditional treatment based on gamma globulin for treatment, and then compare the two groups of treatment. Results The total effective rate of the observation group was 95.65%, which was 86.96% better than that of the control group. The difference between the two groups was statistically significant (P <0.05), and all the patients had no side effects. Conclusion The treatment of viral myocarditis with gamma globulin, the treatment effect was significant and improve the cure rate of the disease, and no adverse reactions, deserved to be widely promoted clinical treatment.